1. Home
  2. FSI vs INKT Comparison

FSI vs INKT Comparison

Compare FSI & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$6.30

Market Cap

82.2M

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$11.93

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
INKT
Founded
1991
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.2M
70.6M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
FSI
INKT
Price
$6.30
$11.93
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
21.1K
37.3K
Earning Date
04-15-2026
05-15-2026
Dividend Yield
1.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,494,325.00
N/A
Revenue This Year
$63.39
N/A
Revenue Next Year
$43.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.22
$6.80
52 Week High
$11.48
$76.00

Technical Indicators

Market Signals
Indicator
FSI
INKT
Relative Strength Index (RSI) 49.80 54.93
Support Level $5.89 $10.79
Resistance Level $6.67 $12.55
Average True Range (ATR) 0.22 1.01
MACD -0.02 0.19
Stochastic Oscillator 52.08 67.05

Price Performance

Historical Comparison
FSI
INKT

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The company also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: